Epigenetics Market
The epigenetics market involves the study of gene expression changes that don't alter the DNA sequence, providing the necessary tools, technologies, and services for this research. Key customers include academic research institutions, clinical research organizations, hospitals, and pharmaceutical and biotechnology companies. The market's growth is primarily driven by a growing awareness of epigenetics' role in disease, rising demand for personalized medicine, and significant advances in sequencing and bioinformatics technologies.
CAGR
15.5%
Compound Annual Growth Rate
Current Value
$22.9B
Estimated 2026
Projected Value
$72.6B
By 2034